These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33933715)

  • 1. MYC protein expression does not correlate with MYC abnormalities detected by FISH but predicts an unfavorable prognosis in de novo acute myeloid leukemia.
    Chen P; Redd L; Schmidt Y; Koduru P; Fuda F; Montgomery-Goecker C; Kumar K; Xu-Monette Z; Young K; Collins R; Chen W
    Leuk Res; 2021 Jul; 106():106584. PubMed ID: 33933715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myeloid leukaemia: expression of MYC protein and its association with cytogenetic risk profile and overall survival.
    Mughal MK; Akhter A; Street L; Pournazari P; Shabani-Rad MT; Mansoor A
    Hematol Oncol; 2017 Sep; 35(3):350-356. PubMed ID: 26856970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double minute chromosomes in acute myeloid leukemia, myelodysplastic syndromes, and chronic myelomonocytic leukemia are associated with micronuclei, MYC or MLL amplification, and complex karyotype.
    Huh YO; Tang G; Talwalkar SS; Khoury JD; Ohanian M; Bueso-Ramos CE; Abruzzo LV
    Cancer Genet; 2016; 209(7-8):313-20. PubMed ID: 27318442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations.
    Luo H; Li Q; O'Neal J; Kreisel F; Le Beau MM; Tomasson MH
    Blood; 2005 Oct; 106(7):2452-61. PubMed ID: 15972450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of MYC oncoprotein expression on survival outcome in patients with acute myeloid leukemia with myelodysplasia related changes (AML-MRC).
    Yun S; Sharma R; Chan O; Vincelette ND; Sallman DA; Sweet K; Padron E; Komrokji R; Lancet JE; Abraham I; Moscinski LC; Cleveland JL; List AF; Zhang L
    Leuk Res; 2019 Sep; 84():106194. PubMed ID: 31357093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m
    Naren D; Yan T; Gong Y; Huang J; Zhang D; Sang L; Zheng X; Li Y
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):33-47. PubMed ID: 32880751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYC protein expression is an important prognostic factor in acute myeloid leukemia.
    Ohanian M; Rozovski U; Kanagal-Shamanna R; Abruzzo LV; Loghavi S; Kadia T; Futreal A; Bhalla K; Zuo Z; Huh YO; Post SM; Ruvolo P; Garcia-Manero G; Andreeff M; Kornblau S; Borthakur G; Hu P; Medeiros LJ; Takahashi K; Hornbaker MJ; Zhang J; Nogueras-González GM; Huang X; Verstovsek S; Estrov Z; Pierce S; Ravandi F; Kantarjian HM; Bueso-Ramos CE; Cortes JE
    Leuk Lymphoma; 2019 Jan; 60(1):37-48. PubMed ID: 29741984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. t(3;8)(q26.2;q24) Often Leads to MECOM/MYC Rearrangement and Is Commonly Associated with Therapy-Related Myeloid Neoplasms and/or Disease Progression.
    Tang G; Hu S; Wang SA; Xie W; Lin P; Xu J; Toruner G; Zhao M; Gu J; Doty M; Li S; Medeiros LJ; Tang Z
    J Mol Diagn; 2019 Mar; 21(2):343-351. PubMed ID: 30576868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of regulatory T cells, CD200 and TIM3 expression in cytogenetically normal acute myeloid leukemia.
    Zahran AM; Mohammed Saleh MF; Sayed MM; Rayan A; Ali AM; Hetta HF
    Cancer Biomark; 2018; 22(3):587-595. PubMed ID: 29843224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MYC cytogenetic status correlates with expression and has prognostic significance in patients with MYC/BCL2 protein double-positive diffuse large B-cell lymphoma.
    Wang XJ; Medeiros LJ; Lin P; Yin CC; Hu S; Thompson MA; Li S
    Am J Surg Pathol; 2015 Sep; 39(9):1250-8. PubMed ID: 25828389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute myeloid leukemia with MYC rearrangement and JAK2 V617F mutation.
    Ohanian M; Bueso-Ramos C; Ok CY; Lin P; Patel K; Alattar ML; Khoury JD; Rozovski U; Estrov Z; Huh YO; Cortes J; Abruzzo LV
    Cancer Genet; 2015 Nov; 208(11):571-4. PubMed ID: 26382622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events.
    Haferlach C; Bacher U; Schnittger S; Alpermann T; Zenger M; Kern W; Haferlach T
    Genes Chromosomes Cancer; 2012 Apr; 51(4):328-37. PubMed ID: 22162288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute Myeloid Leukemia (AML): Upregulation of BAALC/MN1/MLLT11/EVI1 Gene Cluster Relate With Poor Overall Survival and a Possible Linkage With Coexpression of MYC/BCL2 Proteins.
    Akhter A; Farooq F; Elyamany G; Mughal MK; Rashid-Kolvear F; Shabani-Rad MT; Street L; Mansoor A
    Appl Immunohistochem Mol Morphol; 2018 Aug; 26(7):483-488. PubMed ID: 28362701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYC immunohistochemical and cytogenetic analysis are required for identification of clinically relevant aggressive B cell lymphoma subtypes.
    Raess PW; Moore SR; Cascio MJ; Dunlap J; Fan G; Gatter K; Olson SB; Braziel RM
    Leuk Lymphoma; 2018 Jun; 59(6):1391-1398. PubMed ID: 28868942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A new prognostic stratification for patients with acute myeloid leukemia].
    Jiang B; Mi YC; Lin D; Cai XJ; Fu MW; Li W; Wang Y; Liu XP; Xue YP; Bian SG; Wang JX
    Zhonghua Nei Ke Za Zhi; 2009 Apr; 48(4):316-20. PubMed ID: 19576124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AML in Saudi Arabia: Analysis According to the European LeukaemiaNet 2017 Cytogenetic Classification.
    Alabdulwahab AS; Elsayed HG; Sherisher MA; Zeeneldin A; Elbjeirami WM
    Clin Lymphoma Myeloma Leuk; 2020 May; 20(5):e212-e220. PubMed ID: 32127298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prognostic value of minimal residual disease detected by flow-cytometry-enhanced fluorescence in situ hybridization in core-binding factor acute myeloid leukemia (CBF-AML).
    Wang L; Gao L; Xu S; Gong S; Liu M; Qiu H; Xu X; Ni X; Chen L; Lu S; Chen J; Song X; Zhang W; Yang J; Hu X; Wang J
    Ann Hematol; 2014 Oct; 93(10):1685-94. PubMed ID: 24844781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia.
    Tamm I; Richter S; Oltersdorf D; Creutzig U; Harbott J; Scholz F; Karawajew L; Ludwig WD; Wuchter C
    Clin Cancer Res; 2004 Jun; 10(11):3737-44. PubMed ID: 15173080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deciphering the role of Wnt signaling in acute myeloid leukemia prognosis: how alterations in DNA methylation come into play in patients' prognosis.
    Cardona-Echeverry A; Prada-Arismendy J
    J Cancer Res Clin Oncol; 2020 Dec; 146(12):3097-3109. PubMed ID: 32980885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the C-kit receptor (CD117) is a feature of almost all subtypes of de novo acute myeloblastic leukemia (AML), including cytogenetically good-risk AML, and lacks prognostic significance.
    Schwartz S; Heinecke A; Zimmermann M; Creutzig U; Schoch C; Harbott J; Fonatsch C; Löffler H; Büchner T; Ludwig WD; Thiel E
    Leuk Lymphoma; 1999 Jun; 34(1-2):85-94. PubMed ID: 10350335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.